Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Biol Res ; 57(1): 29, 2024 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-38760841

RESUMEN

BACKGROUND: We recently reported that upregulation of Musashi 2 (MSI2) protein in the rare neuromuscular disease myotonic dystrophy type 1 contributes to the hyperactivation of the muscle catabolic processes autophagy and UPS through a reduction in miR-7 levels. Because oleic acid (OA) is a known allosteric regulator of MSI2 activity in the biogenesis of miR-7, here we sought to evaluate endogenous levels of this fatty acid and its therapeutic potential in rescuing cell differentiation phenotypes in vitro. In this work, four muscle cell lines derived from DM1 patients were treated with OA for 24 h, and autophagy and muscle differentiation parameters were analyzed. RESULTS: We demonstrate a reduction of OA levels in different cell models of the disease. OA supplementation rescued disease-related phenotypes such as fusion index, myotube diameter, and repressed autophagy. This involved inhibiting MSI2 regulation of direct molecular target miR-7 since OA isoschizomer, elaidic acid (EA) could not cause the same rescues. Reduction of OA levels seems to stem from impaired biogenesis since levels of the enzyme stearoyl-CoA desaturase 1 (SCD1), responsible for converting stearic acid to oleic acid, are decreased in DM1 and correlate with OA amounts. CONCLUSIONS: For the first time in DM1, we describe a fatty acid metabolism impairment that originated, at least in part, from a decrease in SCD1. Because OA allosterically inhibits MSI2 binding to molecular targets, reduced OA levels synergize with the overexpression of MSI2 and contribute to the MSI2 > miR-7 > autophagy axis that we proposed to explain the muscle atrophy phenotype.


Asunto(s)
Distrofia Miotónica , Ácido Oléico , Ácido Oléico/farmacología , Distrofia Miotónica/tratamiento farmacológico , Distrofia Miotónica/metabolismo , Humanos , Diferenciación Celular/efectos de los fármacos , MicroARNs/metabolismo , Autofagia/efectos de los fármacos , Línea Celular , Proteínas de Unión al ARN/metabolismo
2.
Syst Appl Microbiol ; 27(5): 581-91, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15490560

RESUMEN

Ralstonia solanacerum and Clavibacter michiganensis subsp. sepedonicus are the two most relevant bacterial pathogens of potato for which a large number of molecular diagnostic methods using specific DNA sequences have been developed. About one hundred oligonucleotides have been described and thoroughly tested experimentally. After having compiled and evaluated all these primers and probes in silico to check their specificity, many discrepancies were found. A detailed analysis permitted the recognition of different possible reasons for such discrepancies: sequencing errors in public sequences, wrong supposed specificity (sometimes due to more recent sequences than the oligonucleotides being evaluated) or even typing errors in the oligonucleotides. Although this study is an exercise about in silico evaluation using two potato bacterial pathogens as a model, the conclusions reflect not only information useful for phytopathologists but, in a broader scope, draw the main situations that can be found during an evaluation of probes, which can be surely found in other scenarios.


Asunto(s)
Actinomycetales/clasificación , Actinomycetales/genética , Cartilla de ADN , Sondas de Oligonucleótidos , Ralstonia solanacearum/clasificación , Ralstonia solanacearum/genética , Secuencia de Bases , Sensibilidad y Especificidad , Solanum tuberosum/microbiología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda